Cytos Rises After Asthma Drug Succeeds in Trial: Zurich Mover – Bloomberg

Cytos Rises After Asthma Drug Succeeds in Trial: Zurich Mover
Bloomberg
In a trial among 63 patients in Germany, those treated with the drug, CYT003, had improved control of their asthma after treatment with inhaled corticosteroids stopped, while those who received a placebo saw their disease worsen, Cytos said in a
The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study PR Newswire (press release)

all 3 news articles »

View full post on asthma – Google News